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Abstract
Background: Malnutrition and HIV/AIDS are highly prevalent in Sub-Saharan Africa and they
are linked in a vicious cycle. Intestinal parasite co-infection worsens the effect of malnutrition
among HIV patients. However, the magnitude of malnutrition and its associated factors among
People Living with HIV/AIDS are not well understood at Butajira in particular and in Ethiopia in
general.
Objective: The aim of this study was to assess the prevalence of malnutrition and its associated
factors among Adult People Living with HIV/AIDS receiving ART.
Methods: Institution based cross-sectional study was conducted and systematic random
sampling technique was used to select study subjects. A total of 305 study subjects were enrolled
in the study. Structured and pre-tested questionnaire were used to collect socio-demographic,
clinical and nutritional related data. From each sampled patient, anthropometric and laboratory
data were collected. Both bivariate and multivariate logistic regression analyses were used to
assess the effect of the various factors on the level of malnutrition. P value ≤ 0.05 at 95% CI was
considered statistically significant.
Results: The overall prevalence of malnutrition was 25.2% (95% CI: 20.0% – 30.2%), of which
49(63.6%), 19(24.7%), 9(11.7%) were mildly, moderately and severely malnourished,
respectively. Multivariate Logistic regression analysis revealed that living in rural area
(AOR=1.98, 95% CI: 1.10, 3.53), anemia (AOR=1.94, 95% CI: 1.05, 3.57), eating difficulty
(AOR= 2.69, 95% CI: 1.41, 5.11), using Ready to Use Therapeutic Food (AOR= 0.18, 95% CI:
0.08, 0.40), and intestinal parasitic co-infection (AOR=2.85, 95% CI: 1.54, 5.27) were
significantly associated with malnutrition.
Conclusion: Malnutrition was found to be high among HIV/AIDS patients receiving ART.
Living in rural area, anemia, eating difficulty, Ready Use Therapeutic Food, and intestinal
parasitic co-infection were found to be significant factors associated with malnutrition. To
alleviate the problems, strengthening household food security, following up for intestinal
parasites and anemia consistently, and identifying and treating the cause of poor dietary
consumption as early as possible, should be considered.
Key words: Malnutrition, HIV/AIDS, ART, Intestinal parasites
11. Introduction
Globally, more than 800 million people are chronically undernourished [1] and over 35 million
people are living with Human Immunodeficiency Virus (HIV). Although new cases have been
reported all over the globe, the majority of cases have been reported in low and middle-income
countries, particularly in Sub-Saharan Africa (SSA) [2]. In Ethiopia, 1.5% of adult people aged
15-49 are infected with HIV [3]. Malnutrition combined with Human Immunodeficiency
Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) brought significant crisis in SSA in
particular and globally in general. HIV affects the health status of an individual, and it has an
impact on households, communities and economic growth of the nations. In most developing
countries, malnutrition together with infectious diseases aggravated the HIV/AIDS pandemic and
contributed for both mortality and morbidity of patients [4, 5].
HIV/AIDS and malnutrition effects are interconnected and worsen one another in a vicious
cycle, and cause progressive damage to the immune system independently. HIV specifically
affects nutritional status by reducing food intake, increasing energy requirements, and affecting
nutrient absorption and metabolism adversely [6, 7]. Malnutrition by itself can decrease Cluster
of differentiation (CD4+) T cells and contributes for abnormal B-cell responses [8, 9], which
adversely affects the overall clinical outcome and exacerbates HIV related immune depression
[10].
Estimated Anti Retroviral Therapy (ART) coverage in Ethiopia was 60% with 288 137 people
reported receiving ART in 2012. Since the introduction of ART, the overall morbidity and
mortality due to AIDS and related complications have greatly reduced [11]. However, ART
Medications can cause troubling symptoms like nausea, vomiting, loss of appetites, diarrhea and
other disorders [12]. Metabolic complications are also well observed in adults living with
HIV/AIDS who receive ART, including lipodystrophy, insulin resistance, dyslipidemia, and
osteopenia [13, 14].
Diarrhea adversely affects the nutritional status and causes morbidity and mortality in People
Living with HIV/AIDS (PLWHA) all over the globe particularly in developing countries [15,
16]. Chronic diarrhea is directly associated with more hasten disease progression and death [17].
2Some of the causes of diarrhea are AIDS-defining complications, but virtually parasitic infection
such as Giardia lamblia, Entamoeba histolytica, ascaris lumbrucoids and hookworm may be
responsible [18].
Adequate nutrition is necessary to manage Opportunistic Infections (OI), maintain the immune
system, optimize response to medical treatment, and support optimal quality of life for PLWHA
[19]. Evidence has shown that a good nutrition may contribute to slowing the progression of the
disease. Nutrition interventions can also help to optimize the benefits of antiretroviral drugs and
may increase compliance with treatment regimens [20].
Socio-demographic factors such as gender, income and other environmental factors together with
gastrointestinal complications, OI as a result of AIDS were reported to be factors associated with
malnutrition among PLWHA [21-23].
There are different reports that documented the high magnitude of both malnutrition and
HIV/AIDS in Ethiopia. However, the prevalence of malnutrition among PLWHA is not well
studied in Ethiopia particularly at Butajira. Therefore, the aim of this study was to assess the
prevalence of malnutrition and its associated factors among adult PLWHA receiving ART.
32. Literature Review
The prevalence of malnutrition among PLWHA was reported higher in deferent parts of the
world. In a study conducted in Sao Paulo, Brazil among hospitalized adult AIDS cases, the
prevalence of malnutrition was 43%. Old age was found independently associated with
malnutrition together with very low daily per capital household income [24]. Mariz CA et al also
documented that among 2,018 individuals living with HIV/AIDS in Reo De Jainairo, the
prevalence of underweight was 8.8%. Anemia and CD4+ T cell count < 200mm3 were associated
with under-nutrition [25].
On the other hand, a study conducted in China showed a 37.2% prevalence of malnutrition
measured by Body Mass Index (BMI). The study also reported a significant relationship between
OI with malnutrition [26].
In Spain, among PLWHA, 81.1% were malnourished of which 16.7% were on severe degree of
malnutrition. Degree of immune suppression, chronic hepatitis C virus infection and waist
circumference were associated with malnutrition [27].
A meta-analysis from Demographic and Health Survey (DHS) of 11 SSA countries showed a
10.3% pooled prevalence of HIV-related malnutrition. The pooled prevalence of HIV-related
malnutrition had been higher among women that were unemployed than among women that were
professionally employed, and lower residing in urban areas than rural areas [28].
In Botswana, among HIV-positive adults aged 20 to 50 years, 28.5% were reported malnourished
(BMI < 18.5 kg/m 2). Unintentional weight loss and gastrointestinal symptoms were significantly
associated with a high risk of developing malnutrition [29].
A cross sectional study conducted on 300 adults living with HIV/AIDS in Dakar, Senegal
showed that an overall malnutrition of 39%, of which 14% were severely malnourished. It also
observed that diarrhea and oral candidasis were highly associated to malnutrition [30].
In Kenya, among 497 HIV positive individuals, 20.3% were malnourished of which mild
malnutrition (20.8%), moderate malnutrition (43.6%) and severe malnutrition (35.6%) were
reported. The macronutrient intakes were found no significant association with body composition
at the baseline [22].
4Obi et al documented that among PLWHA in Nigeria, 58.3%  mild to moderate malnutrition and
32.5% Severe malnutrition were reported [31].
The prevalence of malnutrition among PLWHA receiving ART was also reported in different
parts of Ethiopia. A study conducted on 153 HIV-positive adults living in Addis Ababa showed
that 18% were chronically energy deficient. The study also demonstrated that low serum zinc
levels (< 10.7 µmol/L) in 53% of participants,  low serum retinol levels (< 30 µg/dL) in 47% of
participants and low hemoglobin levels (< 12 g/dL) were observed in only 4.72% subjects [32].
In Bahir-Dar, among 408 adult HIV/AIDS clients, the overall prevalence of malnutrition was
25.5%. When the study subjects were stratified as on ART and pre-ART cases, 22.1% and 34.5%
respectively were reported malnourished.  Feeding difficulties, HIV related symptoms and
duration on ART were found to be the predictors of malnutrition [33]. Taye et al also
documented that among 331 adult PLWHA on ART in Gondar, the prevalence of under-nutrition
was 27.8%. Income, nutritional support, presence of eating problems and duration of ART were
found to be the pertinent predictors of malnutrition [34]. The prevalence of malnutrition among
on ART women in Tigray showed that an under-nutrition of 42.3%, severe (12%), moderate
(10%) and mild (20.3%) malnutrition. The prevalence of wasting (body weight loss >5%) was
accounted 75% and severe wasting was 26.9%. Household food insecurity, anemia, inadequate
dietary diversity and absence of nutritional support were found to be predictors of under-
nutrition [35]. Another study conducted in Dilla also reported that, the overall prevalence of
malnutrition in PLWHA was 12.3%. World Health Organization (WHO) clinical stage four,
unemployment, gastrointestinal symptoms and previous one OI and two & above previous OI
were significantly associated with malnutrition [21].
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63. Significance of the Study
In Ethiopia, malnutrition among PLWHA receiving ART has been a major challenge to
accomplish the full impact of intervention. There are different reports that showed large
magnitude of both HIV/AIDS and malnutrition in Ethiopia. However, the burden of malnutrition
among PLWHA receiving ART is not known at Butajira zonal administration in particular.
Moreover, determinants of nutritional status especially intestinal parasitic infection are not
comprehensively studied. Hence, this study was designed to assess the prevalence of
malnutrition and its associated factors among adult HIV/AIDS clients receiving ART at Butajira
Hospital, Southern Ethiopia. The study outcome intern helps to governmental and non-
governmental HIV/AIDS care and support organizations for better nutritional planning and
management for PLWHA care. It also helps to develop appropriate strategy to intervene and
break up the effect of HIV/AIDS and pertinent associated factors on the level of malnutrition.
74. Objectives
4.1. General objective
The major aim of this study was to assess the prevalence of malnutrition and its associated
factors among adult PLWHA receiving ART at Butajira Hospital, Southern Ethiopia, 2014.
4.2. Specific objectives
 To determine the prevalence of malnutrition among adult PLWHA receiving ART.
 To identify the factors associated with malnutrition among adult PLWHA receiving ART.
85. Methods and Materials
5.1. Study area
The study was conducted at Butajira Hospital which is found in Butajira town, Gurage Zone,
Southern Nations Nationalities and People's Region (SNNPR), located 135 km from the capital-
city, Addis Ababa. The town lies on the average at 2,100 meter above sea level. Butajira Hospital
is a zonal hospital with 110 beds that gives health service for people living at Butajira and the
surrounding rural kebeles. A total of 1054 adult HIV/AIDS clients  have  been  enrolled  to  ART
care clinic at Butajira Hospital, of  which 450 were in pre-ART care, and 604 on ART care.
5.2. Study design and period
The study was an institution based cross-sectional study conducted from October, 2013 to June,
2014.
5.3. Population
5.3.1. Source population
The source populations were all adult PLWHA at Butajira town and the surrounding area that
were enrolled for ART follow up service at Butajira Hospital.
5.3.2. Study population
The study populations were people with the age of 18 years and above who were receiving ART.
5.4. Inclusion criteria
Patients who were receiving ART and involved in ART follow up at Butajira Hospital and aged
18 years and above were included in the study.
5.5. Exclusion criteria
Pregnant, lactating mothers (six month of post-partum), seriously ill and/or patients with spinal
deformity were excluded.
95.6. Variables
5.6.1. Dependent variable
Under-nutrition (yes/no)
5.6.2. Independent variables
Socio-demographic variables such as age, sex, marital status, family size, residence,
educational status, occupation, monthly income.
Clinical related variables such as OI, gastrointestinal symptoms, eating difficulty, intestinal
parasites, who clinical stage, CD4+ T cell count, hemoglobin level.
Nutritional related variables such as household food insecurity access (HFIAS), household
dietary diversity (HDD), dietary counseling, and nutritional support.
ART related variables such as drug adherence, duration of ART.
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5.7. Operational definition
Under-nutrition: Adult PLWHA and their BMI less than 18.50 kg/m2 were considered as under-
nutrition based on WHO classification for malnutrition using BMI [36].
Household Food Insecurity Access Scale (HFIAS) is a measure of house hold food
insecurity/security of study subjects in the past four weeks. It was calculated based on nine
questions of food access and it was categorized in to 1 = Food Secure, 2=Mildly Food Insecure
Access, 3=Moderately Food Insecure Access, 4=Severely Food Insecure Access [37].
Household Dietary Diversity (HDD) is the economic ability of a household to access a variety
of foods during the past 24 hrs period. Twelve of the questions were used to assess dietary
diversity. Participants were asked to report the frequency of consumption of each food using the
past 24 hours. Participants received 1 point if they consumed at least once during the last 24
hours of the foods within each subgroup and 0 points if they never consumed the food. The mean
household dietary diversity score in the study subjects was calculated. Then tertiles of the dietary
diversity score were computed with the highest tertile defined as adequate diversified diet, while
the lowest tertiles were inadequate diversified diet [38].
Anemia status was classified by using the level of hemoglobin concentration in g/dl.
Hemoglobin level was ranged between 13–17 and 12–16 g/dl was considered as normal for male
and female patients, respectively [39]. Patients were classified as anemic for females and male
when the hemoglobin concentration was < 12 g/dl and < 13 g/dl respectively.
Drug adherence status was estimated by percent of missed dose enclosed last six months
follow-up time from patient ART follow-up form combined with self reported adherence
measurement technique was used by asking the patients about the number of times they have
missed taking their pills each month and recorded [40].
Good adherence: if the average adherence is greater than 95% (he/she missed < 2 doses of 30
doses or < 3 doses of 60 doses).
Fair adherence: if the average adherence is 85 – 94% (he/she missed 3 – 5 doses of 30 doses or 3
– 9 doses of 60 doses).
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Poor adherence: if the average adherence is < 85 % (he/she missed > 6 doses from 30 doses or >
9 doses of 60 doses).
5.8. Sample size and sampling technique
The sample size was determined using single population proportion formula taking the
prevalence of malnutrition among adults with HIV/AIDS receiving ART 22.1% [33] with 5%
marginal error and 95% confidence interval (CI) of certainty (alpha = 0.05).
Thus the sample size was n =
( ) × ×( ) = ( . ) × . × .( . ) = 265
Where: n = Sample size, p = prevalence of malnutrition (22.1%), q = (1-p), z = critical value
1.96, w= precision (marginal error) = 5%.
In this study, 15% of non-response rate was taken, and the final sample size was 305. Therefore,
305 adult with HIV/AIDS clients were included in the study.
A systematic random sampling technique was used to select the study subjects. According to the
Hospital report, on average 10 – 20 patients currently taking ART have been visiting the Hospital
daily. In order to get sample interval (k), the total population then divided by the sample size
required.
K = 604 ≈ 2
305
Therefore, the first client was taken randomly by lottery method as case one, every other of  the
daily  attended  during  the  data  collection  period  was  included and interviewed until a total of
305 samples were obtained.
5.9. Data collection and laboratory methods
5.9.1. Socio-demographic data
The data was collected from March, 2013 to May 2014 using structured questionnaire. Socio-
demographic characteristics such as age, sex, monthly income, educational and marital status
together with nutrition and clinical related characteristics were collected. Four data collectors
(one nurse, one health officer and two laboratory technicians) and one supervisor were recruited
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and two days training were given. The data collection process was followed daily by the
supervisor and principal investigator.
5.9.2. Laboratory data
Data on hemoglobin, CD4+ T cell count, opportunistic disease in the past six months, WHO
clinical stages of disease, and drug adherence were obtained from patient charts and ART
follow-up forms. CD4+ T cell count was measured with Becton Dickson Fluorescent Activated
Cell Sorter (BD FACS) machine United Status (US) and categorized according to its clinical
significance. Hemoglobin was measured with Cell Dyne hematology analyzer (US). Hemoglobin
level ranged between 13–17 and 12–16 g/dl was considered as normal for male and female
patients, respectively. Patients were graded anemic when the hemoglobin concentration was < 12
g/dl and < 13 g/dl for male and female patients respectively.
5.9.3. Anthropometric data
Anthropometric measurements (weight, height) were recorded by trained nurse. Weight of the
participants was measured in kilograms and recorded to the nearest 0.1 kg using standard beam
balance and the scale was checked at zero before and after each measurement. Each participant
was asked to remove heavy clothes. Measurement of height was conducted using the standard
measuring scale and recorded to the nearest 0.5 cm. The participants were asked to take off their
shoes, stand erect, and look straight in vertical plain. The occipital, shoulder, buttocks, and the
heel touch the standing measuring board.
5.9.4. Sample collection and microscopy
Approximately two gram stool samples were collected in a clean leak proof cupped plastic
container following standard operating procedures. Each sample was examined by two clinical
laboratory technicians independently for intestinal parasites using direct microscopic and
concentration methods at Butajira Hospital parasitology Laboratory. In the case of direct
microscopic examination, stool samples were mixed with physiological saline (0.85% NaCl) on a
microscope slide and covered with a cover slip then examined microscopically using low power
objective first and high dry power objective to examine cysts of intestinal parasites.
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In the case of formal-ether concentration method, about 2 gram or 2 ml of stool sample was
mixed with about 10 ml of normal saline solution and thoroughly mixed. This was filtered
through two layers of gauze into a centrifuge test tube and centrifuged for one minute at a speed
25000 rpm. When the supernatant fluid was very cloudy, the deposit was washed again by
mixing it with 10 ml of normal saline. After pouring or removing the supernatant fluid, 10 ml of
formaldehyde solution (10% formalin solution) was added to the sediment. After mixing the
suspension well and allowed to stand for 5 minute, 3 milliliter of ether was added and
immediately stopper and vigorously shake for 30 seconds. The preparation centrifuged for one
minute at low speed usually 1500 rpm. There appeared four layers in the preparation; the first
layer which is ether, the second layer debris, the third layer formaldehyde solution and the fourth
layer which is the deposit containing stages of parasites (cysts, egg and/or larvae). The
supernatant was removed by tilting the tube and pour off all the fluid. The sediment mixed with
the remaining small fluid and about two drops of the deposit was placed on a slide, to which a
drop of iodine solution was added and covered with cover slide. The entire preparation was
examined using 10X objective for protozoa eggs and 40X objective for cysts.
5.9.5. Quality control
There were a continuous monitoring of test quality and comprehensive checking of all steps. The
questionnaire was adapted and modified in to our context from previous literatures.  It was
prepared first in English and then translated into the local language Amharic, and then
retranslated back to English by an expert to maintain its consistency. Training was given for data
collectors and supervisor. Pre-testing of the questionnaire was made on 20 patients receiving
ART in the nearby Health Center a week prior to the actual survey. Data collection process was
strictly followed day to day by the supervisor and principal investigator. Aseptic techniques and
standard operating procedures were followed during sample collection, processing,
transportation and identification of intestinal parasites.
5.9.6. Data analysis and interpretation
Data was checked  for  completeness,  coded,  and  first entered in  to  EPI-info  version 7,  then
it was  rechecked  and  transferred to  Statistical  Package  for  Social  Science  (SPSS) version
20 for analysis. Chi-square was used to carry out descriptive analysis. Bivariate and multivariate
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logistic regression analyses were used to assess the effect of the various factors on the level of
malnutrition and to control possible confounders. The absence of multi-co-linearity was checked
by using VIF/tolerance. The model adequacy was checked by using Hosmer and Lemeshow
goodness of fit test. P-value ≤ 0.05 at 95% CI was considered statistically significant.
5.9.7. Dissemination of results
Results of this study will be disseminated through publication, presentation on conferences and
seminars. A copy of it will be offered to Butajira hospital, the region (SNNPR), University of
Gondar, School of Biomedical and Laboratory science and other concerned organizations.
5.9.8. Ethical consideration
Ethical clearance was  obtained  from  ethical  review  committee  of  University  of  Gondar,
College  of  Medicine  and  Health  Sciences, School of Biomedical and Laboratory Sciences
prior to  data  collection. Permission was taken from Butajira Zonal Hospital administrators.
Written informed consent was obtained from each participant after the purpose of the study
explained. Participants were told that they had full right not to participate and they were also
informed that all the data obtained from them would be kept confidential using codes instead of
any personal identifiers. Any study participants who are positive for intestinal parasite were
referred to ART clinicians for treatment. Finally, those participants identified as under-nutrition
were given nutritional counseling and RUTF in collaboration with the clinicians working in ART
clinic at Butajira hospital.
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6. Results
6.1. Socio-demographic characteristics of the study participants
A total of 305 adult PLWHA receiving ART were involved in this study giving a response rate
of 100%. The majority of participants (60.7%) were in the age group of 30 – 44 years with the
mean and Standard Deviation (±SD) age of 39.5 (± 9.9) years. The majority (62 %) of study
participants were women. More than half (50.5%) of the study participants were currently
married. The majority of participants (86.6%) have low monthly income (<1000 Ethiopian birr
(ETB) as shown in (Table 1).
6.2. Clinical profiles and ART status of the study participants
More than 3/5th of the study participants (60.3%; n= 184) were at WHO clinical stage I. One
hundred twenty seven patients (41.6%) had current or past history of opportunistic infections, of
which 73 patients (23.9%) had tuberculosis infection and accounted for the uppermost co-
infection. The median CD4+ T cell count and mean hemoglobin concentration level of
participants were 400 cells/μl with inter-quartile range (329 IQR) and 13.0 g/dl with SD ±1.7,
respectively (Table 2).
The majority of patients, 132 (43.3%) were on ART regimen 1e (TDF+3TC+NVP) followed by
1c (AZT+3TC+NVP), (122(40%). However, most patients (38.7%) had changed the ART
regimen due to toxicity/side effects during follow up period (Table 2).
6.3. Nutrition related characteristics of the study participants
Data on the household food insecurity and dietary diversity status showed that more than 3/4th
(79%) of participants were food insecure, of which 14 (4.6%), 99 (32.5%), 128 (42%) were
mildly, moderately and severely food insecure respectively. The mean household dietary
diversity was 4.93 with SD +1.8. Moreover, 121 (39.7%) participants were with inadequate
dietary diversity (Table 3).
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Table 1: Socio-demographic characteristics of the study participants at Butajira Hospital,
Southern Ethiopia, 2014, (n = 305)
Characteristics Frequency (n) Percent (%)
Sex Male 116 38.0
Female 189 62.0
Age 18 – 29 36 11.8
30 – 44 185 60.7
> 45 84 27.5
Marital status Single 19 6.2
Married 154 50.5
Divorced 42 13.8
Widowed 81 26.6
Separated 9 3.0
Family size < 3 148 22.8
4 – 6 137 21.1
>6 20 3.1
Educational status Unable to read and write 121 39.7
Able to read and write 38 12.5
Primary education 80 26.2
Secondary education 47 15.4
Tertiary education 19 6.2
Religion Orthodox 143 46.9
Muslim 102 33.4
Protestant and Catholic 60 19.7
Ethnicity Gurage 178 58.4
Silitie 55 18.0
Amhara 40 13.1
Oromo 14 4.6
Hadiya 18 5.9
Occupation Governmental employer 40 13.1
Self employer 51 16.7
Farmer 39 12.8
Merchant 45 14.8
Daily laborer 60 19.7
House wife 49 16.1
Jobless 21 6.9
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Residence Urban 177 58.0
Rural 128 42.0
Monthly income in
ETB
<1000 264 86.6
>1000 41 13.4
Table 2: Clinical profiles and ART status of the study participants at Butajira Hospital,
Southern Ethiopia, 2014, (n = 305)
Variables Frequency(n) Percent (%)
Eating difficulty No 235 77.0
Yes Problems 70 23.0
Loss of appetite 63 20.7
Vomiting 20 6.6
Nausea 13 4.3
Swallowing   difficulty 6 2
Gastrointestinal
symptoms
No 255 83.6
Yes Problems 50 16.4
Diarrhea
Indigestion
Constipation
28 9.2
22 7.2
7 2.7
WHO clinical stage Stage I 184 60.3
Stage II 54 17.7
Stage III 60 19.7
Stage IV 7 2.3
CD4+ T cell count <200 cells/μl 51 16.7
200 – 350 cells/μl 73 23.9
351 - 500 cells/μl 76 24.9
>500 cells/μl 105 34.4
Anemia status Normal 220 72.1
Anemic 85 27.9
Current/past OI in the past
six months
No 178 58.4
Yes Problems 127 41.6
Acute/chronic Diarrhea 45 14.8
Tuberculosis 73 23.9
Oral thrush 17 5.6
Oral ulcer 8 2.6
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Pneumonia 8 2.6
Zoster 3 1.0
Pneumocystis carinii 1 0.3
ART regimens 1a (d4T+3TC+NVP) 7 2.3
1c (AZT+3TC+NVP) 122 40.0
1d (AZT+3TC+EFV) 14 4.6
1e (TDF+3TC+EFV) 132 43.3
1f (TDF+3TC+NVP) 26 8.5
2b (TDF+3TC+LPV/r) 4 1.3
Duration of ART < 6 month 38 12.5
6 – 12 month 47 15.4
1 – 3 years 53 17.4
> 3 years 167 54.8
Regimen change No 187 61.3
Yes 118 38.7
Reasons  for change Toxicity/side effect
New Tuberculosis
117 38.4
1 0.3
Drug adherence Good 277 90.8
Fair 20 6.6
Poor 8 2.6
N.B: AZT= Zidovudine, d4T= Stavudine, EFV= Efavirenz, NVP= Nevirapine
TDF= Tenofovir, 3TC= Lamivudine, LPV/r = Lopinavir + Ritonavir
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Table 3: Nutrition related characteristics of the study participants at Butajira Hospital,
Southern Ethiopia, 2014, (n = 305)
Variables Frequency (n) Percent (%)
Change of feeding style
after knowing HIV status
No 227 74.4
Yes 75 24.6
Type of change of feeding
style
Frequency 18 5.9
Quality of food 75 24.6
Quantity 3 1.0
Dietary counseling No 143 46.9
Yes 162 53.1
Organizational support other
than medication
No 263 86.2
Economical support 7 2.3
RUTF 26 8.5
Economical and RUTF 9 3.0
Household food insecurity
status
Food secured 64 21.0
Mildly food in secured 14 4.6
Moderately food  in secured 99 32.5
Severely food in secured 128 42.0
Household dietary diversity Inadequate 121 39.7
Adequate 184 60.3
6.4. Intestinal parasite infection among the study participants
More than quarter (26.6%) of the study participants were co-infected with one or more intestinal
parasites and six different types of intestinal parasitic species were identified. Entanmoeba
histolytica/dispar accounted for 11.5% (n= 35) and that of Taenea species for 7.2% (n=22)
followed by Giardia lambelia for 5.3 % (n=16) (Table 4).
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Table 4: Intestinal parasites co-infection among the study participants at Butajira Hospital,
Southern Ethiopia, 2014, (n = 305)
Intestinal parasites Frequency (n) Percent (%)
Negative 224 73.4
Positive 81 26.6
Protozoa’s Entanmoeba histolytica/dispar trophozoite 22 7.2
Entanmoeba histolytica/dispar cyst 13 4.3
Giardia lamblia trophozoite 14 4.6
Giardia lamblia cyst 2 0.7
Helminthes Tanea species 22 7.2
Ascaris lumbricoides 9 3.0
Strongyloid stercoralis 5 1.6
Hookworm species 2 0.7
Multiple
parasitic
infections
Entanmoeba histolytica/dispar trophozoite +
Giardia lamblia trophozoite
2 0.7
Entanmoeba histolytica/dispar trophozoite +
Ascaris lumbricoides
2 0.7
Giardia lamblia trophozoite + Tanea species 1 0.3
6.5. Prevalence of malnutrition
The overall prevalence of malnutrition (BMI < 18.5 kg/m2) among PLWHA receiving ART at
Butajira hospital was 25.2% (95% CI: 20.0% – 30.2%). Mild, moderate and severe malnutrition
was observed on 49 (16.1%), 19 (6.2%) and 9(3.0%) participants respectively (Figure 2). The
mean BMI for male and female was 20.77 (SD ± 3.15) and 21.04 (SD ± 3.56) respectively. The
prevalence of malnutrition among male patients was 25.9% (95% CI: 18.3% – 34.3%) but 24.9%
(95% CI: 18.8% – 31.2%) among females. The prevalence of malnutrition was also different by
the age of the study subjects. Among 77(25.2%) malnourished subjects, the age group 30 – 44
were mostly affected, 42 (13.8 %) followed by the age group above 44 years 29 (9.5%).
6.6. Factors affecting Malnutrition
In this study, both bivariate and multivariate logistic regression analysis was computed.
However, on multivariate logistic regression analysis, out of eleven selected variables in
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bivariate analysis, five variables (residence, eating difficulty, RUTF, anemia and
intestinal parasitic infection) were significantly associated with malnutrition. Six variables that
showed association on the bivariate model (age, educational status, gastrointestinal symptoms,
diarrhea, HFIS and HDD) were not statistical associated with malnutrition in the multivariate
(Table 5). In addition, being rural area dweller was significantly associated with malnutrition (P
= 0.02).  Patients living in rural area were two times more likely to be malnourished as compared
to those living in urban areas (AOR=1.98;  95% CI: 1.10, 3.53). Eating difficulty was also
positively associated with malnutrition (P= 0.002). Participants who had one or more eating
difficulty were 2.69 times more likely to be malnourished as compared to those who were free of
eating difficulty (AOR= 2.69;  95% CI:1.41, 5.11). RUTF was negatively associated with
malnutrition. Individuals who were not taking RUTF were 82% times less likely to be
malnourished than those who were taking RUTF (AOR= 0.18; 95% CI: 0.08, 0.40). Anemia was
also positively associated with malnutrition (P= 0.03). Participants who were anemic were 1.94
more likely to be malnourished than those with normal hemoglobin level (AOR=1.94; 95% CI:
1.05, 3.57). Intestinal parasitic co-infection was also significantly associated with malnutrition.
(P= 0.001).  Participants who had one or more intestinal parasites were 2.85 times more likely to
be malnourished as compared to those who were free of intestinal parasites (AOR=2.85; 95%
CI:1.54, 5.27) (Table 5).
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Table 5: Factors associated with malnutrition among PLWHA receiving ART at Butajira
Hospital, Southern Ethiopia, 2014, (n= 305)
Predictors Under-nutrition COR (95%CI) AOR (95% CI) P- values
Yes No
Age
18 – 29 6 30 1
30 – 44 42 143 1.47(0.57 - 3.76)
> 44 29 55 2.64(0.98 – 7.06)
Residence
Urban 35 142 1 1
Rural 42 86 1.98(1.17 – 3.34) 1.98(1.10 – 3.53) 0.02*
Educational status
Unable to read and write 40 81 2.63(0.72 – 9.57)
Able to read and write 12 26 2.46(0.60– 10.08)
Primary education 16 64 1.33(0.35 - 5.14)
Secondary education 6 41 0.78(0.17- 3.50)
Tertiary education 3 16 1
Eating difficulty
Yes 29 41 2.76(1.56- 4.88) 2.69(1.41 – 5.11) 0.002*
No 48 187 1 1
Gastrointestinal
symptoms
Yes 18 32 1.87(0.98 – 3.57)
No 59 196 1
Diarrhea
Yes 12 16 2.45(1.10 – 5.43)
No 65 212 1
RUTF
Yes 22 13 1 1
No 55 215 0.15(0.07 – 0.3) 0.18(0.08 – 0.40) 0.00**
Anemia
Yes 31 54 2.17(1.25 – 3.76) 1.94(1.05 – 3.57) 0.03*
No 46 174 1 1
HFIS
Food secure 6 58 1
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Mildly food insecure 2 12 1.61(0.29 – 8.97)
Moderately food insecure 26 73 3.44(1.33 – 8.92)
Severely food insecure 43 85 4.89(1.95 – 12.2)
HDD
Inadequate 37 84 1.59(0.94 – 2.67)
Adequate 40 144 1
Intestinal parasite
Present 33 48 2.81(1.62 – 4.89) 2.85(1.54 – 5.27) 0.001**
Absent 44 180 1 1
N.B:  α = 0.05, * shows significant, ** shows highly significant
Hosmer and lemeshow test was at p = 0.39
Stepwise (Backward LR) was used in logistic regression
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7. Discussion
This study focused on assessing the prevalence of malnutrition and its associated factors among
adult PLWHA receiving ART. In this study, the overall prevalence of malnutrition (25.2%) was
relatively lower than other reports conducted in different parts of the world (37.2% - 43%) [24,
26, 30]. The prevalence of malnutrition was also reported different in different part of Ethiopia.
For example, Hailemariam et al reported relatively a 12.3% prevalence of malnutrition at Dilla
[21]. However, a relatively higher prevalence of malnutrition was reported at Tigray (42.3%)
[35]. The result of the current study was relatively similar with previous reports conducted at
Gondar and Bahir-Dar [33, 34]. The discrepancy of malnutrition among different parts of the
country may reflect the existence of different socio-economic and other factors that are practiced
by these communities probably as a result of different ethnic experiences. Moreover, the study
conducted at Tigray was only on women patients which may raise the prevalence of malnutrition
since women are biologically, socially and economically more vulnerable to both HIV/AIDS and
malnutrition [41, 42]. women have lower muscle mass and greater amount of total body fat than
men with an equivalent BMI, which may increase the prevalence of malnutrition, since sex and
muscle mass can affect the relationship between BMI and body fat [43].
Patients living in rural area were two times more likely to be malnourished as compared to those
living in urban areas. People living in rural area showed relatively higher prevalence of
malnutrition compared with urban dwellers. It will not be unwise to expect lower socio-
economic status, reduced awareness about nutrition, lower food access and diversity, and
narrower availability of health, water, and sanitation services in rural dwellers than people living
in urban in the study area as these are commonly observed in third world and developing
countries.
Presence of eating difficulty was another significantly associated variable with malnutrition
among PLWHA receiving ART. Participants who had one or more eating difficulty were 2.69
times more likely to be malnourished as compared to those who were free of eating difficulty.
This finding is in accordance with the results of former studies conducted at Gondar and Bahir-
Dar [33, 34]. Reduction of food consumption due to loss of appetite, vomiting and nausea due to
the side effects of ART, swallowing difficulty due to oral thrush or ulcer leading to reduced
energy intake and also may be the main reason why people lose weight among PLWHA [44] .
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This study found a significant positive association between anemia and malnutrition. Participants
who were anemic were 1.94 fold more likely to be malnourished than those with normal
hemoglobin level. Similar reports were documented in a study conducted at Tigray [35]. This
positive association of anemia with malnutrition might be due to alterations in bone marrow and
spleen erythropoiesis, diminution in reticulocyte as a result of protein-energy malnutrition.
Haemopoietic tissue has a high rate of regeneration and cellular proliferation, presents a high
demand for protein for the process of haemopoiesis. Bone marrow atrophy is common in protein-
energy malnutrition, which result from abnormalities of stem cells or defects in stromal cells,
which would alter the haemopoietic microenvironment [45].
There was also a significant negative association betteween RUTF with malnutrition in the
current study. Individuals who were not taking RUTF were 82% times less likely to be
malnourished than those who were taking RUTF and this was also in accordance with previous
reports [35]. However, the current result on the association of RUTF with malnutrition
contradicts with a report from other countries such as Central Haiti [46] and Uganda [47]. A
number of reasons can contribute for the difference including the study design. The former
studies conducted in Central Haiti were prospective Cohort study, which have enough time to
observe the potential effect of RUTF on that of malnutrition. On the other hand, the participants
of the current study may not take RUTF properly due to sharing to their family members, selling
to get money and they may not respond to RUTF due to recurrent opportunistic infections,
clinical stages of disease and others.
The other pertinent finding of the current study was a highly significant positive association of
intestinal parasites with malnutrition. Participants who had one or more intestinal parasites were
2.85 times more likely to be malnourished as compared to those who were free of intestinal
parasites. This positive association might be due to nutrient demand of parasite itself, frequent
episode of diarrhea and reduced appetite, blocking of the absorbing surface of the mucosa by
adult worms and altered the absorption of nutrients [48, 49]. Many of the populations at high risk
for HIV also live in highly endemic areas of intestinal parasitic infections, which are mainly
acquired in child hood and remain as chronic infections into adult hood [50]. Several
investigators reported lower levels of hemoglobin as a result of pathogenic intestinal parasitic
infection [51]. Entanmoeba histolytica leads to necrosis of intestinal mucosa and bleeding;
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Gardia lamblia to mala-absorption and Tricuris is suggested to associate with anemia mediating
through iron deficiency caused by blood loss [52]. Infection by Hook worm causes iron
deficiency anemia [53] and Ascaris lumbricoids is known to influence nutritional status, but its
impacts on anemia are less clear [54].
8. Strength of the study
The strengths of this study were incorporated assessment of some pertinent variables such as
intestinal parasites which were not examined on the level of malnutrition in previous similar
studies and other medical related problems associated with malnutrition. Patients’ medical charts
and ART follow up data base combined with the primary data collected by structured interview
administered questionnaire were used to avoid recall biases.
9. Limitation of the study
The limitation of the current study could be the study design as the cross-sectional study design
by its nature limits information about cause and effect relationship in the majority of predictors.
In this study, only anthropometric measurement (BMI) was used to assess the nutritional status
of participants, which assess mainly the public health burden of malnutrition. The study didn’t
add some laboratory methods used to assess nutritional status like micronutrient deficiencies.
Assessment of HFIS and HDD depends on the past one month period and 24 hour recall method,
respectively; they may create a possibility of recall bias.
10. Conclusion
This study revealed that malnutrition is high among PLWHA receiving ART. People living in
rural area and patients with eating difficulty, anemia, RUTF, and intestinal parasite co-infection
were the most significant factors affecting malnutrition.
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11. Recommendation
To Federal Ministry of Health (FMOH) and other concerned Non-Governmental Organizations
 Attention should be given to strengthening household food security status of patients
besides nutritional support and ART care.
To clinicians and other health workers
 Consistent and proper detection of intestinal parasites and treat promptly even if the
patients are being asymptomatic or do not have any complaints, in addition to
deworming.
 Regular check up of hemoglobin concentration, diagnosing anemia, identifying the
underlying cause of anemia and intervention should be taken as early as possible.
 Due attention should be given to identify the cause of poor dietary consumption (eating
difficulty) and treat promptly.
To researchers
 In this study, to assess the effect of RUTF on the level of malnutrition was very difficult.
Prospective Cohort study and randomized controlled experimental study design are
recommended to assess the effect of RUTF on nutritional status in PLWHA receiving
ART.
.
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Annex-1: Questionnaires
Consent form
Questionnaire prepared for collection of data on assessment of malnutrition and associated
factors in adult HIV/AIDS clients receiving ART at Butajira hospital, Southern Ethiopia.
Identification_________________
Date of interview______________
Time at the beginning of the interview____________
Introduction
Hello! Madam/sir
My name is_________________, I am data collector for the research by a team of researchers
from university of gondar. The purpose of this quastionnaire is to gather information on
prevalence and associated factors of malnutrition among adult HIV/AIDS clients following HIV
care in Butajira hospital. the research will be beneficial to those adults on HIV/AIDS care and
support.
Confidentiality and informed consent statement
I am going to ask you a series of quastions which will take few minutes and then there will be
measured your weight and height, and stool will be collected and investigated for intestinal
parasites. Your answers to those quastions will remain confidential. I will not write your name in
the quastionnare. You can refuse to any of the qustions and you can interrupt at any point in the
interview. your role in the success of the research is of immense importance and we appreciate
your contribution to the research. Your participation in this study does not involve any direct risk
or benefit for you but is very useful since your answers, as well as those other participant, will
help to those living with HIV/AIDS nutrional care and support. Would you like to participate in
the study?
A. Yes_______                             B. No______
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Thank you for being voluntary to participate in the study!
Result code___________ (1. completed, 2. Partially completed, 3. Refused, 4. Other)
Checked by supervisor, name and signature_____________________________
Patient ID.__________ Unique ART no________
Section one: Socio-demographic background
S.NO. Questions Response categories remarks
101 Sex 1. Male
2. Female
102 Age _________ years
103 Religion 1. Orthodox
2. Muslim
3. Protestant
4. Catholic
5. Others specify______
104. Ethnicity 1. Gurage
2. Silitie
3. Amhara
4. Oromo
5. Tigrie
6. Other specify______
105. Marital Status 1. Single
2. Married
3. Divorced
4. Widowed
5. Separated
106. Family size ________
106. Residence 1. Urban
2. Rural
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107. Educational Status 1. unable to read and write
2. able to read and write
3. primary education
4. secondary education
5. tertiary education
108. Occupation 1. Governmental employer
2. Self employer
3. Farmer
4. Merchant
5. Daily laborer
6. Other specify_______
109. Monthly  income _________
Section two: Clinical characteristics of clients
S. NO. Questions Response categories remark
201. When did you first test positive for
HIV?
______________
202. Do you have any changes on feeding
style after knowing you HIV status?
0. No (skip to 203)
1. Yes
202.a If the answer is yes for question 202,
what is the change on feeding style?
1. Frequency
2. Quality
3. Quantity
4. Other specify_____
203. Do have any problem with eating? 0. No (skip to 204)
1. Yes
203.a If the answer is yes question 203,
what kind of problems do you have?
1. Loss of appetite
2. Vomiting
3. Nausea
4. Swallowing difficulty
5. Other specify_______
36
204. Do you have any gastrointestinal
symptoms?
0. No (skip to 205)
1. Yes
204.a If the answer is yes question 204,
what kind of gastrointestinal
symptoms?
1. Diarrhea
2. Indigestion
3. Constipation
4. Other specify_______
205. Do you have any chronic diseases
other than HIV/AIDS?
0. No (skip to 206)
1. Yes
205.a If yes to question 205, which one is
do you have?
1. Tuberculosis
2. Diabetes mellitus
3. Renal disease
4. Heart disease
5. Other specify_______
206. Have you been given dietary
counseling?
0. No
1. Yes
207. Is there any organization that
supports you?
0. No
1. Yes
208. What supports did you get? 1. Economic
2. RUTF
3. Medication and kits
4. Other specify______
209. Who provide you the support? 1. Government organizational
2. Non-governmental
organization
3. other specify_____
Section three: Data will be extracted from patient medical chart and anthropometry data
s.no Questions Response categories remark
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301. Date of the patient first came to the
ART clinic
_____________________
302. Current/past opportunistic infections 0. No (skip to 303)
1. Yes
302.a If yes to question 302, what kind of
opportunistic infection?
1. Chronic/acute diarrhea
2. Pulmonary tuberculosis
3. Thrush (oral, vaginal)
4. Ulcer (oral, genital)
5. Zoster
6. Bacterial pneumonia
7. Toxoplasmosis
8. Other specify______
303. Current patient’s WHO clinical stage 1. stage I
2. stage II
3. stage III
4. stage IV
304. Current patient’s CD4+ cell count ______________
305. Current patient’s hemoglobin level ____________
306. Take the weight and record to the
nearest 0.1kg
_____________
307. Take the height and record to the
nearest 0.5cm
_____________
308. Current Patient’s BMI (Kg/m2) _____________
Section four: Questions for patients on ART status
S.NO Questions Response categories remark
401. Started date of ART treatment __________
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402. What is the current ART regimen ? __________
403. Was there any regimen change of the
patient?
0. No
1. Yes
403.a If the answer is yes to question 403,
what was the reason?
1. Toxicity/ Side effect
2. Due to new tuberclosis
3. Immunologic failure
4. Virology failure
5. Clinical failure
6. pregnancy
7. Other specify____
404. Drug adherence 1. Good
2. Fair
3. Poor
404.a If fair or poor adherence, what was
the reason?
1. Toxicity/side effect
2. Forgot
3. Stigma, discloser
4. Too ill
5. Felt better
6. Lost/ran out of pills
7. Others
Section 5: Household Food Insecurity Access Scale (HFIAS) Measurement Tool
S.N Questions Response categories
501. In the past four weeks, did you worry
that your household would not have
enough food?
0 = No (skip to Q502)
1=Yes
501.a How often did this happen? 1 = Rarely (once or twice in the
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past four  weeks)
2 = Sometimes (three to ten times
in the past  four weeks)
3 = Often (more than ten times in
the past four weeks)
502. In the past four weeks, were you or
any household member not able to eat
the kinds of foods you preferred
because of a lack of resources?
0 = No (skip to Q503)
1=Yes
502.a How often did this happen? 1 = Rarely (once or twice in the
past four weeks)
2 = Sometimes (three to ten times
in the past four weeks)
3 = Often (more than ten times in
the past four weeks)
503. In the past four weeks, did you or any
household member have to eat a
limited variety of foods due to a lack
of resources?
0 = No (skip to Q504)
1 = Yes
503.a How often did this happen? 1 = Rarely (once or twice in the
past four weeks)
2 = Sometimes (three to ten times
in the past four weeks)
3 = Often (more than ten times in
the past four weeks)
504. In the past four weeks, did you or any
household member have to eat some
foods that you really did not want to
eat because of a lack of resources to
obtain other types of food?
0 = No (skip to Q505)
1 = Yes
504.a How often did this happen? 1 = Rarely (once or twice in the
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past four weeks)
2 = Sometimes (three to ten times
in the past four weeks)
3 = Often (more than ten times in
the past four weeks)
505. In the past four weeks, did you or any
household member have to eat a
smaller meal than you felt you
needed because there was not enough
food?
0 = No (skip to Q506)
1 = Yes
505.a How often did this happen? 1 = Rarely (once or twice in the
past four weeks)
2 = Sometimes (three to ten times
in the past four weeks)
3 = Often (more than ten times in
the past four weeks)
506. In the past four weeks, did you or any
other household member have to eat
fewer meals in a day because there
was not enough food?
0 = No (skip to Q7)
1 = Yes
506.a How often did this happen? 1 = Rarely (once or twice in the
past four weeks)
2 = Sometimes (three to ten times
in the past four weeks)
3 = Often (more than ten times in
the past four weeks)
507. In the past four weeks, was there ever
no food to eat of any kind in your
household because of lack of
resources to get food?
0 = No (skip to Q508)
1 = Yes
507.a How often did this happen? 1 = Rarely (once or twice in the
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past four weeks)
2 = Sometimes (three to ten times
in the past four weeks)
3 = Often (more than ten times in
the past four weeks)
508. In the past four weeks, did you or any
household member go to sleep at
night hungry because there was not
enough food?
0 = No (skip to Q509)
1 = Yes
508.a How often did this happen? 1 = Rarely (once or twice in the
past four weeks)
2 = Sometimes (three to ten times
in the past four weeks)
3 = Often (more than ten times in
the past four weeks)
509. In the past four weeks, did you or any
household member go a whole day
and night without eating anything
because there was not enough food?
0 = No
1 = Yes
509.a How often did this happen? 1 = Rarely (once or twice in the
past four weeks)
2 = Sometimes (three to ten times
in the past four weeks)
3 = Often (more than ten times in
the past four weeks)
Section 6: Dietary Diversity Questionnaire
S.N food group Examples yes=1
no=0
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601. Cereals corn/maize, rice, wheat, sorghum, millet or any other
grains or foods made from these (e.g. bread, noodles,
porridge or other grain products)
602. white roots and
tubers
white potatoes, white cassava, kocho or other foods
made from roots
603. Vegetables red sweet pepper, dark green leafy vegetables,
including wild forms + locally available vitamin a
rich leaves such as cassava leaves, spinach, tomato,
onion
604. Fruits ripe mango, ripe papaya, dried peach, and 100% fruit
juice made from these + other locally available
vitamin A rich fruits, other fruits, including wild
fruits and 100% fruit juice made from these
605. Meat liver, kidney, heart or other organ meats or  blood-
based foods, beef, pork, lamb, goat, chicken
606. Eggs eggs from chicken
607. fish and seafood fresh or dried fish
608. legumes, nuts and
seeds
dried beans, dried peas, lentils, nuts, seeds or foods
made from these (eg. hummus, peanut butter)
609. milk and milk
products
milk, cheese, yogurt or other milk products
610. oils and fats oil, fats or butter added to food or used for cooking
611. Sweets sugar, honey, sweetened soda or sweetened juice
drinks, sugary foods such as chocolates, candies,
cookies and cakes
612. spices,
condiments,
beverages
spices (black pepper, salt), condiments (soy sauce,
hot sauce), coffee, tea, alcoholic beverages
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Section seven: Identification of Intestinal parasites using microscope
701. Intestinal parasites 0. Absent
1. Present
701.a Protozoan 1. Entanmoeba
histolytica/dispar
trophozoit
2. Entanmoeba
histolytica/dispar cyst
3. Giardia lamblia trophozoit
4. Giardia lamblia cyst
5. Other specify_________
701.b Helminthes 1. Ascaris lumbricoides
2. Strongyloid stercoralis
3. Schistosoma mansoni
4. Hookworm species
5. Tinea species
6. Other specify_______
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Annex-2: Questionnaires Amharic version (የአማረኛ መጠይቅ)
በቡታጅራ ሆስፒታል በፀረ ኤች አይ ቪ ክልኒክ ውስጥ የመድሃኒት ክትትል ላይ ባሉ የኤች አይ ቪ/ኤድስ ህሙማን ላይ
የምግብ እጥረት እና ከምግብ እጥረት ጋር የተያያዙ ጉዳዮችን ለማጥናት የተዘጋጀ መጠይቅ፡፡
መለያ ቁጥር …………………..
ቀን ……………………………..
መጠየቁ የተጀመረበት ሰዓት…………..
መግቢያ
ጤና ይስጥልኝ!
ስሜ …………………. ይባላል፡፡ የኔ የስራ ድርሻ በጎንደር ዩኒቨርስቲ የምርምር ባለሙያዎች ቡድን አማካኝነት
በቡታጅራ ሆስፒታል ላይ በሚደረገው ጥናት መረጃ ሰብሳቢ ነኝ:: የመጠይቁ ዓላማ የምግብ እጥረት ደረጃና ከዚህ ጋር
የተያያዙ ጉዳዮች መረጃ ለመሰብሰብ ነው፡፡ የዚህ ምርምር ውጤት ወደፊት ለኤች አይ ቪ ህሙማን ድጋፍ እና እንክብካቤ
ጠቀሜታ ይኖረዋል ፡፡
በመጠየቁ ሂደት አንዳንድ ጥያቄዎች፣ የቁመትና የክብደት መለካት፣ የሰገራ ምርመራም ይኖራል፡፡ ሆኖም የተወሰነ ደቂቃ
ይወስዳል ፡፡ ይህ የሚሰጡት መልስ ለምርምር መሳካት እጅግ ተቃሚ ነው፡፡ ይህ መጠይቅ በሚሞላበት ጊዜ ለመረጃ
ሚስጥራዊነት ሲባል ስምዎትን አንፅፍም ፡፡ በመጠየቁ ወቅት በማንኛውም ሰዓት መጠየቁን ማቋረጥ ይችላሉ፡፡ የርሶዎ ሚና
ለምርምሩ መሳካት እጅግ ተቃሚ ነው እንዲሁም ለምርምሩ ለሚያደርጉልን አስተዋፆኦ እናደንቃለን ፡፡
በዚህ ጥናት ወደፊት እርሶዎ ሌሎች ተሳታፊዎች ምንም እንኳን በቀጥታ ተጠቃሚ ባይሆንም ከኤች አይ ቪ ጋር ለሚትኖሩት
ህሙማን እንክብካቤ ና መሻሻል ጠቀምታ ይኖረዋል ፡፡ በጥናቱ ላይ ለመሳተፍ ፍቃደኛ ነዎት?
ሀ አዎ ለ/ አይደለም
በጥናቱ ለመሳተፍ ፍቃደኛ ስለሆኑ እናመሰግናለን!
ክፍል አንድ፡ አጠቃላይ ስነ - ማህበራዊ ሁኔታ
ተ.ቁ ጥያቄዎች አማረጭ መልሶች አስተያየት
101 ፆታ 1. ወንድ
2. ሴት
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102 እድሜ በአመት __________
103 ሐይማኖት 1. ኦርቶዶክስ
2. ሙስሊም
3. ፕሮቴስታንት
4. ካቶሊክ
5. ሌላ ካላ ይገልጽ________
104 ብሔር 1. ጉራጌ
2. ስልጤ
3. አማራ
4. ኦሮሞ
5. ትግሬ
6. ሌላ ካለ ይገለጽ………
105 የትዳር ሁኔታ 1. ያላገቡ
2. ባለትዳር
3. አግብተው የፈቱ
4. ባል / ሚስት የሞተባቸው
5. ተለያይተው የሚኖሩ
106 በቤት ዉስጥ ያሉት
የቤተሰብ ብዛት
...........................
107 የመኖሪያ ስፍራ 1. ከተማ
2. ገጠር
108 የትምርት ሁኔታ 1. ማንበብና መፃፍ የማይችሉ
2. ማንበብና መፃፍ የሚችሉ
3. አንደኛ ደረጃ ትምህርት
4. ሁለተኛ ደረጃ ትምህርት
5. ከፍተኛ ደረጃ ትምህርት
109 የስራ ሁኔታ 1. የመንግስት ሰራተኛ
2. የግል ሰራተኛ
3. አርሶ አደር
4. ነጋዴ
5. የቀን ሰራተኛ
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6. ሌላ ካለ ይገለጽ………
110 የወር ገቢዎት ምን ያህል
ነው?
………………………
ክፍል ሁለት: የኤች አይቪን እና የበሽታዎች በተመለከተ
ተ.ቁ ጥያቄዎች
201 ለመጀመሪያ ጊዜ ኤች አይ ቪ በደምዎት መኖሩን
ያወቁት መቼ ነው?
…………………..
202 ኤች አይ ቪ በደምዎት መኖሩን ካወቁ በኋላ
ያደረጉት ያመጋገብ ለውጥ አለ?
0. የለም (ወደ 203 ይሂዱ)
1. አዎ
202.ሀ ለጥያቄ ቁጥር 202 መልሶዎ አዎ ከሆነ ምን አይነት
ያመጋገብ ለውጥ ነው?
1. ቶሎ ቶሎ መመገብ
2. ጥራት ያለው ምግብ መመገብ
3. ብዛት ያለው ምግብ መመገብ
4. ሌላ ካለ ይጥቀሱ ……..
203 ሲመገቡ የሚገጥመዎ ችግር አለ? 0. የለም (ወደ 204 ይሂዱ)
1. አዎ
203.ሀ ለጥያቄ ቁጥር 203 መልሶዎ አዎ ከሆነ ችግሮዎት
ምንድን ነው?
1. የምግብ ፍላጎት መቀነስ
2. ማስመለስ
3. የምግብ ፍላጎት መቀነስ/
ማስመለስ
4. የመዋጥ ችግር
5. ሌላ ካለ ይጥቀሱ…….
204 ከሆድ ዕቃ ጋር የተያያዘ በሽታ አለበዎት? 0. የለብኝም(ወደ 205 ይሂዱ)
1. አዎ
204.ሀ ምን አይነት የሆድ ዕቃ በሽታ አለቦዎት? 1. ተቅማጥ
2. መግብ አለመፈጨት
3. ሆድ ድርቀት
4. ሌላ ካለ ይጥቀሱ…..
205 ለብዙ ጊዜ የቆየ በሽታ አለቦዎት? 0. የለም(ወደ 206 ይሂዱ)
1. አዎ
205.ሀ ለጥያቄ ቁጥር 205 አዎ ከሆነ ከሚከተሉት ውስጥ 1. ሳንባ ነቀርሳ
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የትኛው ነው? 2. ስኳር
3. ኩላሊት በሽታ
4. የልብ በሽታ
5. ሌላ ካለ ይጥቀሱ
206 በቆይታዎ ወቅት ስለ አመጋገቦዎት የተሰጠዎት
የምክር አገልግሎት አለ?
0. የለም
1. አዎ
207 ኤች አይ ቪ በደሞዎት በመኖሩ የሚያገኙት ድጋፍ
እና እንክብካቤ አለ?
0. የለም
1. አዎ
207.ሀ የሚደረግለዎት ድጋፍና እንክብካቤ ምንድን ነው? 1. የገንዘብ
2. የምግብ
3. ሌላ ካለ ይጥቀሱ………
207.ለ ድጋፍና እንክብካቤ ሚያደርግሎዎት ድርጅት ማን
ነው?
1. መንግስት
2. መንግስታዊ ያልሆነ ድርጅት
3. ማህበራዊ የሆነ ድርጅት
4. ሌላ ካለ ይጥቀሱ……
ክፍል ሶስት: ከህሙማኑ መዝገብ በማየት፣ ክብደትና ቁመት በመለካት የሚሞላ
ተ.ቁ
301 የኤች አይ ቪ ኤድስ እሙማኑ ወደ ፀረ ኤች አይ ቪ
ክፍል የመጣበት ጊዜ
………. ቀን …… ወር ………. ዓ.ም
302 አሁን/ በፊት ተጓዳኝ ህመም ነበረበት 0. የለበትም( ወደ 303 ይሂዱ)
1. አለበት
302.ሀ ተጓዳኝ ህመሙ ምን ነበር? 1. የቆየ ተቅማጥ
2. ሳንባ ነቀርሳ
3. የአፍ ዉስጥ ቁስል
4. ሌላ ካለ ይጥቀሱ………
303 የህመሙ ደረጃ በአለም ጤና ድርጅት መሰረት 1. ደረጃ 1
2. ደረጃ 2
3. ደረጃ 3
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4. ደረጃ 4
304 አሁን የህሙማኑ CD4 counts ስንት ነው …………………..
305 አሁን የህሙማኑ hemoglobin መጠን ስንት ነው ……………………
306 አሁን ያለውን የህሙማኑ ክብደት በኪሎ ግራም
መዝነው፣ 0.1 ኪ.ግ አስጠጋግተው ያስቀምጡት …………………….
307 አሁን ያለው የህሙማኑ ቁመት በሲኒቲ ሜትር
ለክተው 0.5 ሴ.ሜ አስጠጋግተው ያስቀምጡ …………………….
308 BMI (ኪ.ግ/ሜ2) …………………….
ክፍል አራት፡ የፀረ - ኤች አይ ቪ መድሀኒት ህክምና ላይ የተመለከተ ጥያቄዎች
401. የፀረ ኤች ቪ መድሀኒት ህክምና ከጀመሩ ስንት
ጊዜያት ነው?
…………………
402. ህሙማኑ በአሁኑ ጊዜ የሚጠቀመው የፀረ ኤች ቪ
መድሀኒት ……………………
403 ህሙማኑ በቆይታው ወቅት የተደረገለት የፀረ ኤች
አይ ቪ መድሃኒት ለውጥ ነበር
0. የለም
1. አዎ
403.ሀ የፀረ ኤች አይ ቪ መድሃኒት የተቀየረላቸው ከሆነ
ምክንያቱ ምን ነበር?
1. የመድሃኒቱ አለመስማማት/የጎን ጉዳት
2. በሳንባ በሽታ
3. ሌላ ካለ ይጥቀሱ……………..
404 የመድሃኒት ክትትል 1. ጥሩ
2. መካከለኛ
3. አነስተኛ
404.ሀ የመድሃኒት ክትትሉ መካከለኛ ወይም አነስተኛ ከሆነ
ምክንያቱ ምን ነበር?
1. የመድሃኒቱ አለመስማማት/የጎን ጉዳት
2. የመርሳት ችግር
3. አድሎ እና መገለልን በመፍራት
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4. በጠና ህመም
5. የተሻልኝ ስለመሰለኝ
6. መድሃኒቱ ስላለቀብኝ
7. ሌላ ካለ ይጥቀሱ……………..
ክፍል 5፡ የቤት ዉስጥ በቂ የምግብ መጠን መለኪያ ጥያቄዎች
501 ላለፉት አራት ሳምንታት በቤት ዉስጥ በቂ ምግብ
ላይኖር ይችላል በማለት ተጨንቀዋል?
0. አይደለም (ወደ 502 ይሂዱ)
1. አዎ
501.ሀ መች መች ጊዜ (ምን ያህል ቀናት) ነው የተከሰተው? 1. ከስንት አንዴ(ከአራቱ ሳምንታት ዉስጥ
አንዴ ወይም ሁለቴ)
2. አልፎ አልፎ(ከአራቱ ሳምንታት ዉስጥ
ከ3-10 ቀናት)
3. አብዛኛሁን ቀናት(ከአራቱ ሳምንታት
ከ10 ቀናት በላይ)
502 ላለፉት አራት ሳምንታት በቤት ዉስጥ አንተ /አንቺ
ወይም የቤተሰብዎ አባላት በገንዘብ እጥረት ምክንያት
ምትፈሊጊውን/ ምትፈልገውን ምግብ መብላት
ያልቻልክበት ቀናት ነበር?
0. አይደለም (ወደ 503 ይሂዱ)
1. አዎ
502.ሀ መች መች ጊዜ (ምን ያህል ቀናት) ነው የተከሰተው? 1. ከስንት አንዴ(ከአራቱ ሳምንታት ዉስጥ
አንዴ ወይም ሁለቴ)
2. አልፎ አልፎ(ከአራቱ ሳምንታት ዉስጥ
ከ3-10 ቀናት)
3. አብዛኛሁን ቀናት(ከአራቱ ሳምንታት
ከ10 ቀናት በላይ)
503 ላለፉት አራት ሳምንታት በቤት ዉስጥ አንተ /አንቺ
ወይም የቤተሰብዎ አባላት በገንዘብ እጥረት ምክንያት
ዉስን የምግብ አይነት ለመብላት ተገድሀል?
0. አይደለም (ወደ 504 ይሂዱ)
1. አዎ
503.ሀ መች መች ጊዜ (ምን ያህል ቀናት) ነው የተከሰተው? 1. ከስንት አንዴ(ከአራቱ ሳምንታት ዉስጥ
አንዴ ወይም ሁለቴ)
2. አልፎ አልፎ(ከአራቱ ሳምንታት ዉስጥ
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ከ3-10 ቀናት)
3. አብዛኛሁን ቀናት(ከአራቱ ሳምንታት
ከ10 ቀናት በላይ)
504 ላለፉት አራት ሳምንታት በቤት ዉስጥ አንተ /አንቺ
ወይም የቤተሰብዎ አባላት በገንዘብ እጥረት ምክንያት
መብላት ማትፈልገውን ጥቂት ምግብ ለመብላት
ተገድሀል?
0. አይደለም (ወደ 505 ይሂዱ)
1. አዎ
504.ሀ መች መች ጊዜ (ምን ያህል ቀናት) ነው የተከሰተው? 1. ከስንት አንዴ(ከአራቱ ሳምንታት ዉስጥ
አንዴ ወይም ሁለቴ)
2. አልፎ አልፎ(ከአራቱ ሳምንታት ዉስጥ
ከ3-10 ቀናት)
3. አብዛኛሁን ቀናት(ከአራቱ ሳምንታት
ከ10 ቀናት በላይ)
505 ላለፉት አራት ሳምንታት በቤት ዉስጥ አንተ /አንቺ
ወይም የቤተሰብዎ አባላት በቂ ምግብ ባለመኖሩ
ምክንያት መብላት ከምትፈልገው በታች ምግብ
ለመብላት ተገድሀል?
0. አይደለም (ወደ 506 ይሂዱ)
1. አዎ
505.ሀ መች መች ጊዜ (ምን ያህል ቀናት) ነው የተከሰተው? 1. ከስንት አንዴ(ከአራቱ ሳምንታት ዉስጥ
አንዴ ወይም ሁለቴ)
2. አልፎ አልፎ(ከአራቱ ሳምንታት ዉስጥ
ከ3-10 ቀናት)
3. አብዛኛሁን ቀናት(ከአራቱ ሳምንታት
ከ10 ቀናት በላይ)
506 ላለፉት አራት ሳምንታት በቤት ዉስጥ አንተ /አንቺ
ወይም የቤተሰብዎ አባላት በቂ ምግብ ባለመኖሩ
ምክንያት በቀን ውስጥ ትንሽ ምግብ ለመብላት
ተገድሀል?
0. አይደለም (ወደ 507 ይሂዱ)
1. አዎ
506.ሀ መች መች ጊዜ (ምን ያህል ቀናት) ነው የተከሰተው 1. ከስንት አንዴ(ከአራቱ ሳምንታት ዉስጥ
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አንዴ ወይም ሁለቴ)
2. አልፎ አልፎ(ከአራቱ ሳምንታት ዉስጥ
ከ3-10 ቀናት)
3. አብዛኛሁን ቀናት(ከአራቱ ሳምንታት
ከ10 ቀናት በላይ)
507 ላለፉት አራት ሳምንታት በቤት ዉስጥ አንተ /አንቺ
ወይም የቤተሰብዎ አባላት በገንዘብ እጥረት ምክንያት
ምንም አይነት ምግብ ሳይበሉ የቆዩበት ቀን ነበር?
0. አይደለም (ወደ 508 ይሂዱ)
1. አዎ
507.ሀ መች መች ጊዜ (ምን ያህል ቀናት) ነው የተከሰተው? 1. ከስንት አንዴ(ከአራቱ ሳምንታት ዉስጥ
አንዴ ወይም ሁለቴ)
2. አልፎ አልፎ(ከአራቱ ሳምንታት ዉስጥ
ከ3-10 ቀናት)
3. አብዛኛሁን ቀናት(ከአራቱ ሳምንታት
ከ10 ቀናት በላይ)
508 ላለፉት አራት ሳምንታት በቤት ዉስጥ አንተ /አንቺ
ወይም የቤተሰብዎ አባላት በቂ ምግብ ባለመኖሩ
ምክንያት በርሃብ የተኛበት ምሽት አለ
0. አይደለም (ወደ 509 ይሂዱ)
1. አዎ
508.ሀ መች መች ጊዜ (ምን ያህል ቀናት) ነው የተከሰተው 1. ከስንት አንዴ(ከአራቱ ሳምንታት ዉስጥ
አንዴ ወይም ሁለቴ)
2. አልፎ አልፎ(ከአራቱ ሳምንታት ዉስጥ
ከ3-10 ቀናት)
3. አብዛኛሁን ቀናት(ከአራቱ ሳምንታት
ከ10 ቀናት በላይ)
509 ላለፉት አራት ሳምንታት በቤት ዉስጥ አንተ /አንቺ
ወይም የቤተሰብዎ አባላት በቂ ምግብ ባለመኖሩ
ምክንያት ቀኑን እና ምሽቱን ሙሉ ምንም አይነት
ምግብ ሳትበላ ያደርክበት ቀን ነበር?
0. አይደለም
1. አዎ
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509.ሀ መች መች ጊዜ (ምን ያህል ቀናት) ነው የተከሰተው? 1. ከስንት አንዴ(ከአራቱ ሳምንታት ዉስጥ
አንዴ ወይም ሁለቴ)
2. አልፎ አልፎ(ከአራቱ ሳምንታት ዉስጥ
ከ3-10 ቀናት)
3. አብዛኛሁን ቀናት(ከአራቱ ሳምንታት
ከ10 ቀናት በላይ)
ክፍል 6፡ በዚህ 24 ሰዓት ዉስጥ የተመገበው የምግብ አይነት መለኪያ ጥያቄዎች
ተ.ቁ የምግብ ምድብ ለምሳሌ 0.አይደለም
1.አዎ
601 የጥራጥሬ ዘር በቆሎ፣ሩዝ፣ስንዴ፣ማሽላ፣ወይም ከነዚህ የጥራጥሬ ዘሮች የተሰሩ
ምግቦች(ለምሳሌ፡- ዳቦ፣ገንፎ፣ዳቦ ቆሎ)
602 የስራስር ምግቦች ድንች፣ስካር ድንች፣ ቆጮ ወይም ከነዚህ ስራስር የተሰሩ ምግቦች
603 አትክልቶች ቀይ በርበሬ፣ቆስጣ፣ሰላጣ፣ሽንኩርት፣ቲማቲም
604 ፍራፍሬዎች ማንጎ፣ፓፓያ፣ቡርትካን ወይም 100% ከነዚህ ፍራፍሬዎች ተሰሩ ጭማቂ
605 ስጋ የከብት ስጋ፣የፍየል ስጋ፣የበግ ስጋ፣የዶሮ ስጋ ወይም ከነዚህ እንሰሳት
ውስጥ የሚገኙ የውስጥ አካላቶች( ለምሳሌ፡- ጉበት፣ኩላሊት፣ልብ)
606 እንቁላል የዶሮ እንቁላል
607 የዓሳ ምግቦች ያልቆየ የደረቀ ዓሳ
608 ባለሁለት ግርባብ
እህሎች
ባቄላ፣አተር፣ምስር፣ኦቾሎኒ፣ወይም ከነዚህ እህሎች የተሰሩ ምግቦቸ
609 ወተት እና የወተት
ውጤቶቸ
ወተት፣አይብ፣እርጎ
610 የዘይት እና የቅባት
ምግቦች
ዘየት፣ቅቤ የተጨመረባቸው ምግቦች
611 ጣፋጭ ምግቦች ስኳር፣ማር፣ጣፋጭ ጭማቂዎች፣ቸኮሌት፣ከረሜላ፣ኬክ
612 ቅመማቅመሞች እና
መጠጦች
ጨው፣ቡና፣ሻይ፣የአልኮል እና የለስላሳ መጠጦች
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ክፍል 7፡ የስገራ ምርምራ በማድረግ የአንጀት ጥገኛ ተዋስያኖቹን መለየት
701 የአንጀት ጥገኛ ተዋስያን አለበት? 0. የለበትም
1. አለበት
701.ሀ Protozoan 1. Entanmoeba histolytica/dispar
trophozoit
2. Entanmoeba histolytica/dispar
cyst
3. Giardia lamblia trophozoit
4. Giardia lamblia cyst
5. Other specify_________
701.ለ Helminthes 1. Ascaris lumbricoides
2. Strongyloid stercoralis
3. Schistosoma mansoni
4. Hookworm species
5. Tinea species
6. Mixed infections
7. Other specify_______
ስለሰጡኝ መልስ አመሰግናለሁ!
የመረጃ ሰብሳቢው ስም …………………….. ፊርማ ………………… ቀን ……………..
የዋና ተመራማሪ ስም ………………… ፊርማ ……………. ቀን ………………
የተቆጣጣሪ ስም…………………. ፊርማ ……………… ቀን……………….
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Annex-3: Laboratory data collection procedures and format
Direct faecal smears-saline and wet mount preparations
Material and reagents:
1. Wooden applicator sticks
2. Slide(75x25mm)
3. Cover slips
4. Pen and markers
5. Isotonic saline solution (0.85%)
6. Lugol’s iodine(1%solution)
Procedure:
1. Write the patients identification number and date at the left hand end of the slide.
2. Place a drop of saline in the center of the left half of the slide and place a drop of iodine
solution in the center of the right half of the slide.
3. With an applicator sticks pick up a small portion of faeces (approximately 2mg) and add
it the drop of saline: add a small portion of iodine.mix the faeces with the drops to form
suspensions.
4. Cover each drop with a cover slip by holding the cover slip at an angle. Touch the edge
of the drop and gently lowering the cover slip on to the slide.
5. Examine the preparations with the 10x objectives or, if needed for identification, higher
laterally.
Formal-ether concentration technique
Materials and reagents:
Funnel                                Conical centrifuge                 Strainer (gauze)           10% formalin
Ethyl acetate/ Ether           Applicator stick                     Slide                             Cover slide
Microscope                         Normal saline                       Centrifuge                    Stopper
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Procedure:
1. Mix the specimen well.
2. Strain 5 ml of the fecal suspension (more or less depending on its consistency) through
wetted cheesecloth-type gauze placed over a disposable paper funnel into a 15 ml conical
centrifuge tube.
3. Add 0.85% saline or 10% formalin through the debris on the gauze to bring the volume in
the centrifuge tube to 15 ml.
4. Centrifuge at 500× g for 10 minutes.
5. Decant supernatant. Add 10 ml of 10% formalin to the sediment and mix thoroughly with
wooden applicator sticks.
6. Add 4 ml of ethyl acetate, stopper the tube, and shake vigorously in an inverted position
for 30 seconds. Carefully remove the stopper.
7. Centrifuge at 500 × g for 10 minutes.
8. Layer  will be seen according to the density ( ether, debris, formalin and sediment)
9. Plug of debris from the top of the tube by ringing the sides with an applicator stick.
10. Decant the top layers of supernatant.
11. Use a cotton-tipped applicator to remove debris from sides of the centrifuge tube.
12. Resuspend the sediment  perform wet mount
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Annex-4: Information sheet and consent form
Title of the research ፡ prevalence of malnutrition and its associated factors among adult
PLWHA receiving ART at Butajira Hospital, Southern Ethiopia.
Name of principal investigator: Dereje Gedle
Name of organization: Gondar University, College of Medicine and Health Science, School of
Biomedical and Laboratory Sciences.
Tel:  +251 913190403
Email address: drakselina@yahoo.com
Advisors: Dr. Baye Gelaw
: Mr. Dagnachew Muluye
: Mr. Molla Mesele
This Information sheet and consent form prepared by University of Gondar College of Health
Science Biomedical and Laboratory Science student and advisors.
Introduction
This information sheet and consent form is prepared with the aim of explaining the research
project that you are asked to join by a group of research investigators. The main aim of the
research project is to assess malnutrition among PLWHA receiving ART care and associated
factors at Butajira hospital, Southern Ethiopia. The investigators include final year master of
infectious and tropical diseases candidate Dereje Gedle and the advisors Dr.Baye Gelaw and Mr.
Dagnachew Muluye from School of Biomedical ond Laboratory Science, College of Medicine
and Health Science, University of Gondar.
Purpose of the research
The aim of this study is to assess prevalence of malnutrition among adult PLWHA receiving
ART care and associated factors at Butajira Hospital, South Ethiopia.
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Procedure
In order to assess malnutrition in adult PLWHA and associated factors with it, we invite you to
take part in our project. If you are willing to participate in our project you need to understand and
sign the consent form. Then you will be requested to give your response to the data collectors.
For this questionnaires based study, participants are all adult PLWHA receiving ART care at
Butajira hospital, Southern Ethiopia. All the responses given by the patients and the results
obtained will be kept confidential using coding system whereby no one will have access it.
Risk and/or discomfort
By participating in this research project you may feel that it has some discomfort specially on
wasting your time (about 20 minute) but this may not be too much as you are coming to this
clinic for routine HIV treatment and care by comparing its potential benefits contributing to
prevent morbidity and mortality in PLWHA. There is no risk/harm to you by participating in this
research project.
Benefits
If you participate in this research project there may not be direct benefit to you but your
participation is likely to help us the extent of malnutrition and factors associated with it in people
living with HIV/AIDS. Furthermore, the information obtained you will be used for planning and
implementation of nutritional care and support for PLWHA.
Incentives/payment for participating
You will not be provided any incentives or payment to take part in this study.
Confidentiality
The information collected from this research project will be confidential. Information collected
about you will be stored in a file which will not have your name on it but a code number
assigned to it and will be kept in a locked cabinet so that no one except the investigator will have
access to it.
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Right to refuse or withdraw
You have the full right to refuse from participating in this research (you can choose not to
respond all or some of the questions) if you don’t wish to participate; and this will not affect your
treatment or health services you get at this hospital in any way. You have also the full right to
withdraw from this study at any time you wish, without losing any of your rights as a patient in
the hospital.
Person to contact
This research project will be reviewed and approved by ethical committee of the University of
Gondar. If you want to know more information you can contact the committee through the
address below. If you have any question you can contact any of the following individuals and
you may ask at any time you want.
1. Dereje Gedle: School of biomedical and laboratory science, CMHS, university of Gondar
Tel: + 251 913190403
2. Dr. Baye Gelaw: School of biomedical and laboratory science, CMHS, university of
Gondar
Tel: + 251 919703723
3. Mr. Dagnachew Muluye: School of biomedical and laboratory science, CMHS, university
of Gondar
Tel: + 251 918031335
4. Mr. Molla Mesele: Institute of public health, CMHS, university of Gondar
Tel: + 251 920254664
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Consent form
I the undersigned have been informed that the interview is conducted to gather information about
prevalence of malnutrition in PLWHA receiving ART, the government, and health facilities
involved in HIV/AIDS care and support to individuals living with HIV/AIDS. I also agreed
about the confidentiality of the response to be at a highest possible level.
Signature of participant: _____________
Name and signature of data collector:_____________________
Annex-5: Information sheet and consent form Amharic Version (የምርምር/ጥናት ማብራሪያና
የስምምነት መግለጫ ቅጽ)
የምርምር/ጥናት ርዕስ
በደቡብ ኢትዮጵያ ቡታጅራ ሆስፒታል በኤች አይ ቪ አድስ ህሙማን ላይ የምግብ እጥረትና ተዛማችነት ያላቸውን
ምክንያቶችን ለማጥናት የሚካሄድ ጥናት ነው ፡፡
የዋና ተመራማሪ ስም ደረጀ ገድለ
አድራሻ ጎንደር ዩኒቨርሲቲ የህክምናና ጤና ሳይንስ ኮሌጅ
ስ.ቁ 0913190403
ኢሜል drakselina@yahoo.com
አማካሪዎች ፡ ዶ/ር ባዬ ገላው
፡ አቶ ዳኛቸውሙልዬ
፡ አቶ ሞላ መሰለ
ይህ ማብራሪያና የስምምነት መግለጫ ቅፅ የተዘጋጀው በጎንደር ዩኒቨርሲቲ ህክምናና ጤና ሳይንስ ኮሌጅ ድህረ ምረቃ ተማሪና
በጎንደር ዩኒቨርሲቲ አማካሪ አማካኝነት ነው ፡፡
መግቢያ
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ይህ በደቡብ ክልል ኢትዮጵያ በቡታጅራ ሆስፒታል በ ኤች አይ ቪ ኤድስ ህሙማን ላይ የምግብ እጥረትና ተዛማች
ምክንያቶችን ለማጥናት የሚካሄድ ሲሆን በጎንደር ጤና ሳይንስ ኮሌጅ የመጨረሻ አመት የሁለተኛ ድግሪ ተማሪ በሆነው
በደረጀ ገድለ እና በአማካሪዎቹ ዶ/ር ባዬ ገላውና እና ዳኛቸውሙልዬ የሚካሄድ ጥናት ነው፡፡
የምርምሩ አላማ
የዚህ ጥናት ዋና አላማ በደቡብ ክልል ቡታጅራ ሆስፒታል ላይ በኤች አይ ቪ ኤድስ ህሙማን የምግብ እጥረት እና ተዛማችነት
ያለቸውን ነገሮች ለማወቅ የሚደረግ ጥናት ነው ፡፡
ያሰራር ሂደት
የኤች አይቪ ኤድስ ህሙማን የምግብ እጥረት እና ለምግብ እጥረት የሚያጋልጡ ጉዳዮች በሚዳስሰው ጥናት እርሶዎ
እንዲሳተፉ ጋብዘነዎታል ፡፡
በዚህ ጥናት ውስጥ ለመሳተፍ ከተስማሙ ስምምነቱን በደንብ በመረዳት ከዚያ በመቀጠል በጥናቱ መረጃ ሰብሳቢዎች
ለሚጠየቁት ጥያቄ እንዲመልሱ ፍቃደኝነቶዎ ይጠየቃሉ፡፡
በዚህ ጥናት የሚሳተፉት በሆስፒታሉ የፀረ- ኤች አይ ቪ መድሃኒት መውሰድ የጀመሩ ላይ ሲሆኑ የሚሰጡት መልስም ሆነ
የሚገኘው ውጤት በሚስጥር ይጠበቃል፡፡
ሊከሰቱ የሚችሉ ስጋቶችና ምቾት መጉደሎች
በዚህ ጥናት መሳተፎዎት ምንልባት ጊዜዎን ሊሻማቦዎት ይችል ይሆናል ፡፡ ነገር ግን ዘወትር ወደ ሆስፒታል ለህክመና
ከመላለሰዎና የጥናቱ ውጤት ወደ ፊት ለህሙማን በህመም ከመሰቃየት እና ከሞት ለመከላከል ከሚሰጠው ጥቅም አንጻር
ችግሩ ይህን ያህል አይደለም በዚህ ጥናት መሳተፎዎ ለምንም አይነት ስጋት አያጋጥምዎትም ፡፡
ጥቅሞች
በዚህ ጥናት መሳተፎ የተለየ ጥቅም አያገኙም ነገር ግን በጥናቱ መሳተፍ የኤች አይቪ ህሙማን መሳተፍ ምን ያህል በምግብ
እጥረት ይጎዳሉ ለሚለው እና ለምግብ የሚያጋልጡ ጉዳዮች በማወቅ ለችግሩ መፍትሄ ለመስጠት የሚደረገውን እንቅስቃሴ
በከፍተኛ ሁኔታ ያግዛል ፡፡
ማካካሻ
በዚህ ጥናት በመሳተፎዎ ምንም አይነት ማካካሻ አይሰጠዎትም ፡፡ ነገር ግን በጥናቱ በመሳተፎዎ ምስጋናችን ከፍተኛ ነው ፡፡
ሚስጥር ስለመጠበቅ
ከዚህ ጥናት የሚገኝ መረጃ በሙሉ በሚስጥራዊነት ይጠበቃል ፡፡ ለዚህ ጥናት የሚሰበሰበው እርሶዎን የሚመለከት መረጃ
በማህደር የሚቀመጥ ሲሆን ማህደሮዎ በስሙዎ ሳይሆን በተለየ ኮድ ሲቀመጥ ኮዱ ከዋናው ተመራማሪ ውጭ ለማንም
አይገለጽም ፡፡
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በጥናቱ ያለመሳተፍ ወይም እራስን የማግለል መብት
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